AMICROBE

News

Amicrobe announces kilogram-scale GMP manufacturing of Amicidins - synthetic proteins to prevent and treat life-threatening infections

To produce clinical-grade Amicidins, Amicrobe selected contract manufacturer Polypeptide Therapeutic Solutions (PTS), a global leader in amino acid polymer synthesis and characterization. In a successful collaboration, Amicrobe's lead biologics, Amicidin-a and Amicidin-β, were produced at kilogram-scale under Good Manufacturing Practice (GMP) guidelines.  The full press release can be viewed here.